PPW
NBIX icon

Parcion Private Wealth’s Neurocrine Biosciences NBIX Stock Holding History

Parcion Private Wealth’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Sell
3,372
-511
-13% -$75.8K 0.03% 243
2026
Q1 		$512K Buy
3,883
+107
+3% +$14.2K 0.03% 226
2025
Q4 		$536K Buy
3,776
+1,344
+55% +$195K 0.03% 222
2025
Q3 		$341K Buy
+2,432
New +$330K 0.02% 255

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parcion Private Wealth's NBIX Position: Q2 2026 in Review

Parcion Private Wealth reduced its Neurocrine Biosciences (NBIX) stake by 13% in Q2 2026, selling an estimated $75.8K and leaving 3,372 shares worth $568K. The position accounts for 0.03% of the portfolio, ranked #243.

Parcion Private Wealth first reported a position in NBIX in Q3 2025 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Parcion Private Wealth held 3,372 shares of Neurocrine Biosciences worth $568K as of Q2 2026.
  • Parcion Private Wealth sold 511 Neurocrine Biosciences shares in Q2 2026, an estimated $75.8K.
  • Neurocrine Biosciences made up 0.03% of Parcion Private Wealth's portfolio in Q2 2026, its #243 holding.
  • Parcion Private Wealth first reported a position in Neurocrine Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.